JNGLX
Price
$68.96
Change
+$0.01 (+0.01%)
Updated
Sep 16 closing price
Net Assets
4.49B
LYFCX
Price
$12.70
Change
-$0.01 (-0.08%)
Updated
Sep 16 closing price
Net Assets
N/A
Interact to see
Advertisement

JNGLX vs LYFCX

Header iconJNGLX vs LYFCX Comparison
Open Charts JNGLX vs LYFCXBanner chart's image
Janus Henderson Global Life Sciences D
Price$68.96
Change+$0.01 (+0.01%)
VolumeN/A
Net Assets4.49B
AlphaCentric Life Sciences & Hlthcare C
Price$12.70
Change-$0.01 (-0.08%)
VolumeN/A
Net AssetsN/A
JNGLX vs LYFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LYFCX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LYFCX is a StrongSell.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
LYFCX pays higher dividends than JNGLX: LYFCX (1.14) vs JNGLX (0.34). JNGLX was incepted earlier than LYFCX: JNGLX (27 years) vs LYFCX (6 years). LYFCX (2.88) is less costly to investors than JNGLX (0.80). LYFCX is a more actively managed with annual turnover of: 164.00 vs. JNGLX (35.00). JNGLX (2500) and LYFCX (2500) have matching initial minimum investment requirements. LYFCX annual gain was more profitable for investors over the last year : -6.39 vs. JNGLX (-15.63). LYFCX return over 5 years is better than : 9.29 vs. JNGLX (4.06).
JNGLXLYFCXJNGLX / LYFCX
Total Expense Ratio0.802.4633%
Annual Report Gross Expense Ratio0.802.8828%
Fund Existence27 years6 years-
Gain YTD1.5763.33347%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.49BN/A-
Annual Yield % from dividends0.341.1430%
Returns for 1 year-15.63-6.39245%
Returns for 3 years11.674.49260%
Returns for 5 years4.069.2944%
Returns for 10 years17.01N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTCT59.690.71
+1.20%
PTC Therapeutics
COHU21.310.15
+0.71%
Cohu
GENC15.11-0.13
-0.85%
Gencor Industries
CRWV118.75-1.72
-1.43%
Coreweave Inc
HTCR1.03-0.05
-4.63%
Heartcore Enterprises